CRAs Play a Supporting Role in Patient-Centric Trials
There is an ever-present desire in the clinical trial industry to practice ‘patient-centricity’. This practice is featured predominantly during the…
There is an ever-present desire in the clinical trial industry to practice ‘patient-centricity’. This practice is featured predominantly during the…
In clinical research, the process of finding and selecting sites is essential to the success of a study, as it…
A biotech sponsor in the United States had targeted July 2015 for completion of enrollment for a Phase I dose-finding HER2+BrCa study.
Over the last decade, increased competition for finite patient populations in the U.S. have led many drug developers to expand…
Back in June of 2011, a leading U.S. biotech company, currently developing multiple therapeutic candidates, was planning a Phase I/II…